NYL Investors’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
19,901
0.65% 25
2026
Q1
$1.5M Hold
19,901
0.57% 27
2025
Q4
$1.35M Hold
19,901
0.46% 28
2025
Q3
$1.13M Sell
19,901
-5,604
-22% -$332K 0.37% 32
2025
Q2
$1.41M Sell
25,505
-5,673
-18% -$266K 0.39% 31
2025
Q1
$1.36M Sell
31,178
-5,802
-16% -$253K 0.09% 31
2024
Q4
$1.59M Hold
36,980
0.14% 31
2024
Q3
$1.65M Sell
36,980
-5,802
-14% -$240K 0.1% 29
2024
Q2
$1.65M Hold
42,782
0.12% 29
2024
Q1
$1.47M Hold
42,782
0.05% 30
2023
Q4
$1.24M Hold
42,782
0.05% 29
2023
Q3
$810K Buy
+42,782
New +$812K 0.03% 29

Other funds holding DBD

NYL Investors's DBD Position: Q2 2026 in Review

NYL Investors held its Diebold Nixdorf (DBD) position steady in Q2 2026 at 19,901 shares worth $1.69M. The position accounts for 0.65% of the portfolio, ranked #25.

NYL Investors first reported a position in DBD in Q3 2023 and has held it in 12 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • NYL Investors held 19,901 shares of Diebold Nixdorf worth $1.69M as of Q2 2026.
  • NYL Investors left its Diebold Nixdorf share count unchanged in Q2 2026.
  • Diebold Nixdorf made up 0.65% of NYL Investors's portfolio in Q2 2026, its #25 holding.
  • NYL Investors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 12 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on NYL Investors's 13F filing for Q2 2026, filed 12 Aug 2026.